Live

Watch: Fed Chair Powell speaks at the Economic Club of Chicago

NSE - Delayed Quote INR

Glenmark Pharmaceuticals Limited (GLENMARK.NS)

1,356.80

-20.10

(-1.46%)

At close: 3:30:00 PM GMT+5:30

Glenmark Pharmaceuticals Ltd (BOM:532296) Q3 2025 Earnings Call Highlights: Robust Revenue ...

Glenmark Pharmaceuticals Ltd (BOM:532296) reports a 35.1% revenue surge in Q3 FY25, driven by strong performance in India and strategic global expansions.

GuruFocus.com last month

GLENMARK.NS
-1.46%
Glenmark to market BeiGene’s oncology medicines in India

Glenmark will manage the necessary development, registration and distribution processes of Tislelizumab and Zanubrutinib.

Pharmaceutical Technology 10 months ago

GLENMARK.NS
-1.46%
BGNE
Cipla and Glenmark initiate recall of certain products in the US

Cipla USA is recalling 59,244 packs of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution.

Pharmaceutical Technology 11 months ago

GLENMARK.NS
-1.46%
CIPLA.NS
+0.99%

Performance Overview

Return	GLENMARK.NS	S&P BSE SENSEX (^BSESN)
YTD	-15.68%	-1.40%
1-Year	+28.18%	+5.62%
3-Year	+187.05%	+32.06%